- Home
- SBFM vs AQB Comparison
SBFM vs AQB Comparison
Compare SBFM & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- AQB
- Stock Information
- Founded
- SBFM 2006
- AQB 1991
- Country
- SBFM United States
- AQB United States
- Employees
- SBFM N/A
- AQB N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- AQB
- Sector
- SBFM Health Care
- AQB
- Exchange
- SBFM Nasdaq
- AQB Nasdaq
- Market Cap
- SBFM 3.7M
- AQB 3.4M
- IPO Year
- SBFM N/A
- AQB N/A
- Fundamental
- Price
- SBFM $2.66
- AQB $0.59
- Analyst Decision
- SBFM Strong Buy
- AQB Hold
- Analyst Count
- SBFM 1
- AQB 2
- Target Price
- SBFM $15.00
- AQB N/A
- AVG Volume (30 Days)
- SBFM 1.8M
- AQB 112.4K
- Earning Date
- SBFM 11-05-2024
- AQB 11-05-2024
- Dividend Yield
- SBFM N/A
- AQB N/A
- EPS Growth
- SBFM N/A
- AQB N/A
- EPS
- SBFM N/A
- AQB N/A
- Revenue
- SBFM $32,959,491.00
- AQB $1,258,512.00
- Revenue This Year
- SBFM $86.70
- AQB N/A
- Revenue Next Year
- SBFM $126.76
- AQB $57.38
- P/E Ratio
- SBFM N/A
- AQB N/A
- Revenue Growth
- SBFM 61.94
- AQB N/A
- 52 Week Low
- SBFM $2.11
- AQB $0.55
- 52 Week High
- SBFM $608.00
- AQB $3.00
- Technical
- Relative Strength Index (RSI)
- SBFM 47.83
- AQB 24.74
- Support Level
- SBFM $2.51
- AQB $0.55
- Resistance Level
- SBFM $2.82
- AQB $0.97
- Average True Range (ATR)
- SBFM 0.29
- AQB 0.08
- MACD
- SBFM -0.02
- AQB -0.03
- Stochastic Oscillator
- SBFM 22.34
- AQB 4.52
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.